T cell immunotherapy for leukaemia in preclinical setting

Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia (CLL)

Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML)

Comment: Transplantation and short telomeres increase the risk of cognitive impairment

Equality of access to transplant for ethnic minority patients

New agents in CLL

Full-intensity transplantation and short telomeres increase risk of cognitive impairment after allogeneic haematopoietic cell transplantation

Targeting tyrosine kinase receptors to tackle CML

Chronic lymphocytic leukaemia: A new treatment era is born

Chemo-free treatment for acute promyelocytic leukaemia

Initial phase III results of the first trial in newly diagnosed multiple myeloma

Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3